Cargando…

A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody

Type C retroviruses endogenous to various nonprimate species can infect human cells in vitro, yet the transmission of these viruses to humans is restricted. This has been attributed to direct binding of the complement component C1q to the viral envelope protein p15E, which leads to classical pathway...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192220/
https://www.ncbi.nlm.nih.gov/pubmed/7595205
_version_ 1782147188863795200
collection PubMed
description Type C retroviruses endogenous to various nonprimate species can infect human cells in vitro, yet the transmission of these viruses to humans is restricted. This has been attributed to direct binding of the complement component C1q to the viral envelope protein p15E, which leads to classical pathway-mediated virolysis in human serum. Here we report a novel mechanism of complement-mediated type C retrovirus inactivation that is initiated by the binding of "natural antibody" [Ab] (anti-alpha-galactosyl Ab) to the carbohydrate epitope Gal alpha 1- 3Gal beta 1-4GlcNAc-R expressed on the retroviral envelope. Complement- mediated inactivation of amphotropic retroviral particles was found to be restricted to human and other Old World primate sera, which parallels the presence of anti-alpha-galactosyl natural Ab. Blockade or depletion of anti-alpha-galactosyl Ab in human serum prevented inactivation of both amphotropic and ecotropic murine retroviruses. Similarly, retrovirus was not killed by New World primate serum except in the presence of exogenous anti-alpha-galactosyl Ab. Enzyme-linked immunosorbent assays revealed that the alpha-galactosyl epitope was expressed on the surface of amphotropic and ecotropic retroviruses, and Western blot analysis further localized this epitope to the retroviral envelope glycoprotein gp70. Finally, down-regulation of this epitope on the surface of murine retroviral particle producer cells rendered them, as well as the particles liberated from these cells, resistant to inactivation by human serum complement. Our data suggest that anti- alpha-galactosyl Ab may provide a barrier for the horizontal transmission of retrovirus from species that express the alpha- galactosyl epitope to humans and to other Old World primates. Further, these data provide a mechanism for the generation of complement- resistant retroviral vectors for in vivo gene therapy applications where exposure to human complement is unavoidable.
format Text
id pubmed-2192220
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21922202008-04-16 A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody J Exp Med Articles Type C retroviruses endogenous to various nonprimate species can infect human cells in vitro, yet the transmission of these viruses to humans is restricted. This has been attributed to direct binding of the complement component C1q to the viral envelope protein p15E, which leads to classical pathway-mediated virolysis in human serum. Here we report a novel mechanism of complement-mediated type C retrovirus inactivation that is initiated by the binding of "natural antibody" [Ab] (anti-alpha-galactosyl Ab) to the carbohydrate epitope Gal alpha 1- 3Gal beta 1-4GlcNAc-R expressed on the retroviral envelope. Complement- mediated inactivation of amphotropic retroviral particles was found to be restricted to human and other Old World primate sera, which parallels the presence of anti-alpha-galactosyl natural Ab. Blockade or depletion of anti-alpha-galactosyl Ab in human serum prevented inactivation of both amphotropic and ecotropic murine retroviruses. Similarly, retrovirus was not killed by New World primate serum except in the presence of exogenous anti-alpha-galactosyl Ab. Enzyme-linked immunosorbent assays revealed that the alpha-galactosyl epitope was expressed on the surface of amphotropic and ecotropic retroviruses, and Western blot analysis further localized this epitope to the retroviral envelope glycoprotein gp70. Finally, down-regulation of this epitope on the surface of murine retroviral particle producer cells rendered them, as well as the particles liberated from these cells, resistant to inactivation by human serum complement. Our data suggest that anti- alpha-galactosyl Ab may provide a barrier for the horizontal transmission of retrovirus from species that express the alpha- galactosyl epitope to humans and to other Old World primates. Further, these data provide a mechanism for the generation of complement- resistant retroviral vectors for in vivo gene therapy applications where exposure to human complement is unavoidable. The Rockefeller University Press 1995-11-01 /pmc/articles/PMC2192220/ /pubmed/7595205 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody
title A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody
title_full A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody
title_fullStr A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody
title_full_unstemmed A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody
title_short A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody
title_sort novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192220/
https://www.ncbi.nlm.nih.gov/pubmed/7595205